Anti-Complement C5 Antibody (Eculizumab)
Catalog No.
F1352
Anti-Complement C5 Antibody (Eculizumab)
Featured Products
Eculizumab (Anti-Human C5, Humanized Antibody) is a long-acting humanized monoclonal antibody against complement C5. Eculizumab inhibits the cleavage of C5 into C5a and C5b, thereby inhibiting the deployment of the terminal complement system, including the formation of the membrane attack complex (MAC). Eculizumab has the potential to be used in hemolytic studies.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.74 kDa
Dry ice
219685-50-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Soliris, h5G1.1
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P01031
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CO5 His at 2 ug/mL can bind Anti-Complement C5 Antibody (Eculizumab)
Complement C5
Please avoid freeze-thaw cycles.